Long-term results after primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 13 9 2018
medline: 23 11 2019
entrez: 13 9 2018
Statut: ppublish

Résumé

To evaluate the long-term outcome after cataract surgery with primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis. The medical records of all 24 children (34 eyes) with chronic juvenile idiopathic arthritis-associated uveitis who underwent cataract surgery between 1990 and 2013 were reviewed retrospectively. Primary intraocular lens implantation was performed in all patients. Median age at diagnosis of uveitis in the first eye was 5.3 years (range: 2.7-9.4 years) and median age at the time of cataract surgery in the first eye was 9.7 years (range: 4.1-16.9 years). Postoperative follow-up time ranged from 1 to 23.1 years, with a median of 10.9 years. Best corrected visual acuity at the last follow-up was good (⩾20/40) in 65% of the eyes. Postoperatively, glaucoma developed in 8 eyes (24%), posterior capsular opacification and secondary membrane formation requiring surgery in 15 eyes (44%), macular oedema in 5 eyes (15%) and phthisis in 2 eyes (6%). This study shows a favourable visual outcome in most of the cases. Primary intraocular lens implantation may be considered in juvenile idiopathic arthritis-associated uveitis complicated by cataract in patients with well-controlled inflammation.

Identifiants

pubmed: 30207174
doi: 10.1177/1120672118799623
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

494-498

Auteurs

Urszula Kulik (U)

St. Erik Eye Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.

Anna Wiklund (A)

St. Erik Eye Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.

Maria Kugelberg (M)

St. Erik Eye Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.

Anna Lundvall (A)

St. Erik Eye Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH